Literature DB >> 19371826

Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients.

Raffaele Marfella1, Clara Di Filippo, Michele Portoghese, Franca Ferraraccio, Maria Rosaria Rizzo, Mario Siniscalchi, Emilio Musacchio, Michele D'Amico, Francesco Rossi, Giuseppe Paolisso.   

Abstract

OBJECTIVES: We analyzed the molecular mechanisms evoked by tight glycemic control during post-infarction remodeling in human hearts.
BACKGROUND: The molecular mechanisms by which tight glycemic control improves heart remodeling during acute myocardial infarction (AMI) are still largely unknown.
METHODS: Eighty-eight patients with first AMI undergoing coronary bypass surgery were studied: 38 normoglycemic patients served as the control group; hyperglycemic patients (glucose >or=140 mg/dl) were randomized to intensive glycemic control (IGC) (n = 25; glucose 80 to 140 mg/dl) or conventional glycemic control (CGC) (n = 25; glucose 180 to 200 mg/dl) for almost 3 days before surgery, with insulin infusion followed by subcutaneous insulin treatment. Echocardiographic parameters were investigated at admission and after treatment period. During surgery, oxidative stress (nitrotyrosine, superoxide anion [O(2)(-)] production, inducible nitric oxide synthase [iNOS]), inflammation (nuclear factor kappa B [NFkappaB], tumor necrosis factor [TNF]-alpha, and apoptosis (caspase-3) were analyzed in biopsy specimens taken from the peri-infarcted area.
RESULTS: Compared with normoglycemic patients, hyperglycemic patients had higher myocardial performance index (MPI) (p < 0.05), reduced ejection fraction (p < 0.05), more nitrotyrosine, iNOS, and O(2)(-) production, more macrophages, T-lymphocytes, and HLA-DR (Dako, Milan, Italy) cells, and more NFkappaB-activity, TNF-alpha, and caspase-3 levels (p < 0.01) in peri-infarcted specimens. After the treatment period, plasma glucose reduction was greater in the IGC than in the CGC group (p < 0.001). Compared with IGC patients, CGC patients had higher MPI (p < 0.02), had lower ejection fraction (p < 0.05), and had more markers of oxidative stress, more inflammation and apoptosis (p < 0.01) in peri-infarcted specimens.
CONCLUSIONS: Tight glycemic control, by reducing oxidative stress and inflammation, might reduce apoptosis in peri-infarcted areas and remodeling in AMI patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371826     DOI: 10.1016/j.jacc.2009.01.041

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  26 in total

Review 1.  An overview of glycemic control in the coronary care unit with recommendations for clinical management.

Authors:  Mikhail Kosiborod; Prakash Deedwania
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

2.  Gambogic acid exerts cardioprotective effects in a rat model of acute myocardial infarction through inhibition of inflammation, iNOS and NF-κB/p38 pathway.

Authors:  Duan Na; Hou Aijie; Luan Bo; Miao Zhilin; Yuan Long
Journal:  Exp Ther Med       Date:  2017-12-05       Impact factor: 2.447

Review 3.  Hyperglycemia in nondiabetic patients presenting with acute myocardial infarction.

Authors:  Binita Shah; Nicholas S Amoroso; Steven P Sedlis
Journal:  Am J Med Sci       Date:  2012-04       Impact factor: 2.378

4.  Diabetes: Glycaemia and insulin after acute myocardial infarction.

Authors:  Paresh Dandona; Ajay Chaudhuri
Journal:  Nat Rev Endocrinol       Date:  2014-07-01       Impact factor: 43.330

5.  Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress.

Authors:  Wai Ho Tang; Wing Tim Cheng; Gennadi M Kravtsov; Xiao Yong Tong; Xiu Yun Hou; Sookja K Chung; Stephen Sum Man Chung
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-23       Impact factor: 4.249

6.  Glucose control using a closed-loop device decreases inflammation after cardiovascular surgery without increasing hypoglycemia risk.

Authors:  Takahiko Tamura; Tomoaki Yatabe; Tsutomu Namikawa; Kazuhiro Hanazaki; Masataka Yokoyama
Journal:  J Artif Organs       Date:  2018-11-19       Impact factor: 1.731

7.  Molecular mechanisms of hyperglycemia and cardiovascular-related events in critically ill patients: rationale for the clinical benefits of insulin therapy.

Authors:  Samer Ellahham
Journal:  Clin Epidemiol       Date:  2010-12-12       Impact factor: 4.790

8.  Acute hyperglycemia and contrast-induced nephropathy in patients with non-ST elevation myocardial infarction.

Authors:  Onur Baydar; Alparslan Kilic
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-02-21

Review 9.  Stress Induced Hyperglycemia in the Context of Acute Coronary Syndrome: Definitions, Interventions, and Underlying Mechanisms.

Authors:  Mingmin Li; Guo Chen; Yingqing Feng; Xuyu He
Journal:  Front Cardiovasc Med       Date:  2021-05-12

10.  Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction.

Authors:  Rudo F Mapanga; Uthra Rajamani; Nonkululeko Dlamini; Makhosazane Zungu-Edmondson; Roisin Kelly-Laubscher; Mohammed Shafiullah; Athiq Wahab; Mohamed Y Hasan; Mohamed A Fahim; Philippe Rondeau; Emmanuel Bourdon; M Faadiel Essop
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.